Dynavax Technologies Corporation Stock Prediction and Forecast [DVAX]

AI-generated source summary

DVAX stock shows positive signals from both short and long-term moving averages, indicating a bullish forecast. The stock has experienced low daily movements and a 14-day RSI of 93, suggesting increased risk. A buy signal was issued from a pivot bottom on December 1, 2025, with the price rising 43.60%. Further upward movement is anticipated until a new pivot top is established. Additionally, a buy signal from the 3-month MACD, coupled with rising volume, supports a positive technical outlook. Analysts have provided a 'Hold/Accumulate' rating, with a target price of $15.42 and a stop-loss at $14.90. The stock is considered undervalued at its current level. On December 26th, DVAX is expected to open higher and begin trading at $15.42. The stock's previous performance shows a 38.19% gain on the last trading day and has exhibited significant price fluctuations over the past two weeks, with a peak at $15.85 and a low at $11.57. Overall, the stock exhibits a generally bullish trend with support levels identified at $11.57 and $11.13.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   25 Dec 2025, 03:54 UTC

   The analyst published the original source item.

2. First prediction resolved

   30 Dec 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   30 Dec 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.